Concepedia

Ash Bullement

AB

14

Publications

413

Citations

12

H-Index

2015

Active since

Affiliations

University College London(Current)

BresMed

University of Sheffield

University of Manchester

Merck (Germany)

Ash Bullement is an author at University College London specializing in engineering, health policy, and medicine.

ORCID

Top concepts

Publications per year

2015–2022

14

Publications

14

Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models

Anthony J. Hatswell, Ash Bullement, Andrew Briggs et al. · PharmacoEconomics · 2018 · 103 citations

, , +12

Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study

Ash Bullement, Nicholas Latimer, Helen Bell‐Gorrod · Value in Health · 2018 · 64 citations

, , +5

Real-world evidence use in assessments of cancer drugs by NICE

Ash Bullement, Tanja Podkonjak, Mark Robinson et al. · International Journal of Technology Assessment in Health Care · 2020 · 40 citations · Full text

Cost-effectiveness of Trifluridine/tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales

Ash Bullement, Stuart Underhill, Ronan Fougeray et al. · Clinical Colorectal Cancer · 2017 · 29 citations · Full text

A comparison of partitioned survival analysis and state transition multi-state modelling approaches using a case study in oncology

Holly Cranmer, Gemma Shields, Ash Bullement · Journal of Medical Economics · 2020 · 29 citations · Full text

Rows per page

1–5 of 14